Publication date: Jan 24, 2025
The COVID-19 pandemic may have impacted disabilities among people living with HIV; however, data on the association between COVID-19 pandemic-related healthcare disruptions and disabilities among people living with HIV is limited. We aimed to evaluate the association between COVID-19-affected HIV care behaviors and disability domains among people living with HIV in Belize. A cross-sectional study was conducted at the Western Regional Hospital and Southern Regional Hospital between August and October 2021 among people living with HIV in Belize aged ≥ 21 years and on antiretroviral therapy. A self-reported questionnaire captured data on demographic and clinical characteristics (gender, age, ethnicity, marital status, employment, education, CD4 count, and viral load), COVID-19-affected HIV care behaviors, and disability across six domains (physical, cognitive, and mental-emotional symptoms and impairments; uncertainty; difficulties carrying out day-to-day activities; and social inclusion challenges) using the Short-Form HIV Disability Questionnaire. Univariate and multivariate logistic regression analyses were employed to analyze the data. Of the 489 participants, 276 (56. 4%) were women and 213 (43. 6%) were men. After adjusting for covariates, (age, gender, employment, CD4 count, viral load, COVID-19-affected HIV care behaviours), our results showed that people living with HIV, whose HIV care behaviors were greatly affected by COVID-19, were more likely to have disabilities across various domains: physical (adjusted odds ratio (AOR): 1. 61, 95% confidence interval (CI): 1. 08-2. 41, p = 0. 018), cognitive (AOR: 2. 49, 95% CI: 1. 58-3. 94, p
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 pandemic |
disease | MESH | marital status |
disease | MESH | viral load |
disease | MESH | uncertainty |
disease | IDO | immunodeficiency |
drug | DRUGBANK | Coenzyme M |
disease | MESH | chronic diseases |
disease | MESH | anxiety |
disease | MESH | depression |
disease | IDO | susceptibility |
disease | IDO | country |
disease | MESH | lost to follow up |
disease | IDO | process |
disease | MESH | HIV infection |
pathway | REACTOME | HIV Infection |
disease | MESH | educational level |
pathway | KEGG | Coronavirus disease |
disease | MESH | complications |
disease | MESH | AIDS |
drug | DRUGBANK | Water |
pathway | KEGG | Viral replication |
disease | MESH | lifestyles |
disease | MESH | infections |
disease | MESH | Tuberculosis |
pathway | KEGG | Tuberculosis |
disease | MESH | emergencies |
disease | MESH | coinfection |
disease | MESH | psychological distress |
drug | DRUGBANK | Acetylcysteine |
pathway | REACTOME | Release |
pathway | REACTOME | Reproduction |